FDA Adverse Event Death Summary report: N

ENDEAVOR SPRINT RX

MDR report key: 7027224 · Received November 14, 2017

Report

Report Number
9612164-2017-01603
Event Type
Death
Date Received
November 14, 2017
Date of Event
September 1, 2017
Report Date
November 14, 2017
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P060033
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KS
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

LITERATURE REFERENCE: DOI.ORG/10.4070/KCJ.2017.0016 MEDTRONIC, INC. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

THE 1,672 PATIENTS WERE RANDOMISED IN THE TRIAL AND 271 OF THESE HAD ENDEAVOR SPRINT DRUG ELUTING STENT IMPLANTED. AT THE 1, 3, 6 AND 12 MONTHS FOLLOW UP, PATIENT DEATH WAS REPORTED ALONG WITH TARGET LESION RELATED MYOCARDIAL INFARCTION, REVASCULARIZATION OF TARGET LESION, STENT EDGE DISSECTION AND STENT THROMBOSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
810386 ENDEAVOR SPRINT RX STENT, CORONARY, DRUG-ELUTING NIQ MEDTRONIC IRELAND UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 64 YR Death